Gusman DJR,
Matheus HR, Alves BES, Ervolino E, de Araujo NJ, Piovezan BR, Fiorin
LG, de Almeida JM. Influence of systemic strontium ranelate on the progression
and as adjunctive therapy for the nonsurgical treatment of experimental
periodontitis. J Clin Exp Dent. 2021;13(12):e1239-48.
doi:10.4317/jced.58827
https://doi.org/10.4317/jced.58827
___________
References
1.
Eke PI, Dye BA, Wei L, et al. Update on Prevalence of Periodontitis in Adults
in the United States: NHANES 2009 to 2012. J Periodontol. 2015;86:611-622. |
|
|
|
2.
Dentino A, Lee S, Mailhot J, Hefti AF. Principles of periodontology.
Periodontol 2000. 2013;61:16-53. |
|
|
|
3.
Genco RJ, Borgnakke WS. Risk factors for periodontal disease. Periodontol
2000. 2013;62:59-94. |
|
|
|
4.
Matthews DC, Tabesh M. Detection of localized tooth-related factors that
predispose to periodontal infections. Periodontol 2000. 2004;34:136-150. |
|
|
|
5.
De Almeida J, Ervolino E, Bonfietti LH, Novaes VCN, Theodoro LH, Fernandes LA,
et al. Adjuvant Therapy With Sodium Alendronate for the Treatment of
Experimental Periodontitis in Rats. J Periodontol. 2015;86:1166-1175. |
|
|
|
6.
Karakan NC, Akpınar A, Göze F, Poyraz Ö. Investigating the Effects of
Systemically Administered Strontium Ranelate on Alveolar Bone Loss
Histomorphometrically and Histopathologically on Experimental Periodontitis
in Rats. J Periodontol. 2017;88:e24-e31. |
|
|
|
7.
Chellan P, Sadler PJ. The elements of life and medicines. Philos Trans A Math
Phys Eng Sci. 2015;373:20140182. |
|
|
|
8.
Li C, Paris O, Siegel S, Roschger P, Paschalis EP, Klaushofer K, et al.
Strontium is incorporated into mineral crystals only in newly formed bone
during strontium ranelate treatment. J Bone Miner Res. 2010;25:968-975. |
|
|
|
9.
Panahifar A, Maksymowych WP, Doschak MR. Potential mechanism of alendronate
inhibition of osteophyte formation in the rat model of post-traumatic
osteoarthritis: evaluation of elemental strontium as a molecular tracer of
bone formation. Osteoarthritis Cartilage. 2012;20:694-702. |
|
|
|
10.
Cianferotti L, D'Asta F, Brandi ML. A review on strontium ranelate long-term
antifracture efficacy in the treatment of postmenopausal osteoporosis. Ther
Adv Musculoskelet Dis. 2013;5:127-139. |
|
|
|
11.
Barrionuevo P, Kapoor E, Asi N, Alahdab F, Mohammed K, Benkhadra K, et al.
Efficacy of Pharmacological Therapies for the Prevention of Fractures in
Postmenopausal Women: A Network Meta-Analysis. J Clin Endocrinol Metab. 2019;104:1623-1630. |
|
|
|
12.
Rizzoli R, Chapurlat RD, Laroche JM, Krieg MA, Thomas T, Frieling I, et al.
Effects of strontium ranelate and alendronate on bone microstructure in women
with osteoporosis. Results of a 2-year study. Osteoporos Int. 2012;23:305-315. |
|
|
|
13.
Pilmane M, Salma-Ancane K, Loca D, Locs J, Berzina-Cimdina L. Strontium and
strontium ranelate: Historical review of some of their functions. Mater Sci
Eng C Mater Biol Appl. 2017;78:1222-1230. |
|
|
|
14.
Souza RB, Gomes FIF, Pereira KMA, Dutra PGP, da Cunha RMS, Chaves HV, et al.
Strontium Ranelate Elevates Expression of Heme Oxygenase-1 and Decreases
Alveolar Bone Loss in Rats. J Oral Maxillofac Res. 2018;9:e4. |
|
|
|
15.
NC3Rs Reporting Guidelines Working Group. Animal research: reporting in vivo
experiments: the ARRIVE guidelines. J Physiol. 2010; 588:2519-2521. |
|
|
|
16.
Gusman DJR, Ervolino E, Theodoro LH, Garcia VG, Nagata MJH, Alves BES, et al.
Antineoplastic agents exacerbate periodontal inflammation and aggravate
experimental periodontitis. J Clin Periodontol. 2019;46:457-469. |
|
|
|
17.
Rosa JA, Sakane KK, Santos KC, Corrêa VB, Arana-Chavez VE, Oliveira JX.
Strontium Ranelate Effect on the Repair of Bone Defects and Molecular
Components of the Cortical Bone of Rats. Braz Dent J. 2016;27:502-507. |
|
|
|
18.
Graves DT, Fine D, Teng YT, Van Dyke TE, Hajishengallis G. The use of rodent
models to investigate host-bacteria interactions related to periodontal diseases.
J Clin Periodontol. 2008;35:89-105. |
|
|
|
19.
Polak D, Wilensky A, Shapira L, Halabi A, Goldstein D, Weiss EI, et al. Mouse
model of experimental periodontitis induced by Porphyromonas
gingivalis/Fusobacterium nucleatum infection: bone loss and host response. J
Clin Periodontol. 2009;36:406-410. |
|
|
|
20.
de Molon RS, de Avila ED, Cirelli JA. Host responses induced by different
animal models of periodontal disease: a literature review. J Investig Clin
Dent. 2013;4:211-218. |
|
|
|
21.
Listgarten MA. Similarity of epithelial relationships in the gingiva of rat
and man. J Periodontol. 1975;46:677-680. |
|
|
|
22.
Klausen B. Microbiological and immunological aspects of experimental
periodontal disease in rats: a review article. J Periodontol. 1991;62:59-73. |
|
|
|
23.
Tat SK, Pelletier JP, Mineau F, Caron J, Martel-Pelletier J. Strontium
ranelate inhibits key factors affecting bone remodeling in human osteoarthritic
subchondral bone osteoblasts. Bone. 2011;49:559-567. |
|
|
|
24.
Tenti S, Cheleschi S, Guidelli GM, Galeazzi M, Fioravanti A. What about
strontium ranelate in osteoarthritis? Doubts and securities. Mod Rheumatol.
2014;24:881-884. |
|
|
|
25.
Alves SM, Abreu SC, Lemos JC, Gomes FIF, Alves SM, do Val DR, et al.
Anti-inflammatory and anti-nociceptive effects of strontium ranelate on the
zymosan-induced temporomandibular joint inflammatory hypernociception in rats
depend on TNF-α inhibition. Pharmacol Rep. 2017;69:764-772. |
|
|
|
26.
Alcaraz MJ, Fernández P, Guillén MI. Anti-inflammatory actions of the heme
oxygenase-1 pathway. Curr Pharm Des. 2003;9:2541-2551. |
|
|
|
27.
Graves DT, Jiang Y, Genco C. Periodontal disease: bacterial virulence
factors, host response and impact on systemic health. Curr Opin Infect Dis.
2000;13:227-232. |
|
|
|
28.
Bartold PM, Van Dyke TE. Host modulation: controlling the inflammation to
control the infection. Periodontol 2000. 2017;75:317-329. |
|
|
|
29.
Eming SA, Wynn TA, Martin P. Inflammation and metabolism in tissue repair and
regeneration. Science. 2017;356:1026-1030. |
|
|
|
30.
Asher R, Chacartchi T, Tandlich M, Shapira L, Polak D. Microbial accumulation
on different suture materials following oral surgery: a randomized controlled
study. Clin Oral Investig. 2019;23:559-565. |
|
|
|
31.
Bernabei R, Martone AM, Ortolani E, Landi F, Marzetti E. Screening, diagnosis
and treatment of osteoporosis: a brief review. Clin Cases Miner Bone Metab.
2014;11:201-217. |
|
|
|
32.
Taubel J, Naseem A, Wang D, Arezina R, Lorch U, Camm AJ. Repeated
supratherapeutic dosing of strontium ranelate over 15 days does not prolong
QT(c) interval in healthy volunteers. Br J Clin Pharmacol. 2012;74:296-303. |